View in EDS HTML Full Text PDF Full Text

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.

Saved in:
Bibliographic Details
Title: Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Authors: Nikolaienko O; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Eikesdal HP; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Ognedal E; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Lundgren S; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Geisler S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Yndestad S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Minsaas L; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Leirvaag B; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Lillestøl R; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Lønning PE; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. per.lonning@helse-bergen.no.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway. per.lonning@helse-bergen.no.
Source: Genome medicine [Genome Med] 2023 Dec 06; Vol. 15 (1), pp. 104. Date of Electronic Publication: 2023 Dec 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38053165
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nikolaienko+O%22">Nikolaienko O</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Eikesdal+HP%22">Eikesdal HP</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Ognedal+E%22">Ognedal E</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Gilje+B%22">Gilje B</searchLink>; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Lundgren+S%22">Lundgren S</searchLink>; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Blix+ES%22">Blix ES</searchLink>; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Espelid+H%22">Espelid H</searchLink>; Department of Surgery, Haugesund Hospital, Haugesund, Norway.<br /><searchLink fieldCode="AU" term="%22Geisler+J%22">Geisler J</searchLink>; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Geisler+S%22">Geisler S</searchLink>; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Janssen+EAM%22">Janssen EAM</searchLink>; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Yndestad+S%22">Yndestad S</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Minsaas+L%22">Minsaas L</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Leirvaag+B%22">Leirvaag B</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Lillestøl+R%22">Lillestøl R</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Knappskog+S%22">Knappskog S</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Lønning+PE%22">Lønning PE</searchLink>; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. per.lonning@helse-bergen.no.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway. per.lonning@helse-bergen.no.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475844%22">Genome medicine</searchLink> [Genome Med] 2023 Dec 06; Vol. 15 (1), pp. 104. <i>Date of Electronic Publication: </i>2023 Dec 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101475844 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-994X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756994X%22">1756994X </searchLink><i>NLM ISO Abbreviation: </i>Genome Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38053165
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13073-023-01262-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104
    Titles:
      – TitleFull: Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nikolaienko O
      – PersonEntity:
          Name:
            NameFull: Eikesdal HP
      – PersonEntity:
          Name:
            NameFull: Ognedal E
      – PersonEntity:
          Name:
            NameFull: Gilje B
      – PersonEntity:
          Name:
            NameFull: Lundgren S
      – PersonEntity:
          Name:
            NameFull: Blix ES
      – PersonEntity:
          Name:
            NameFull: Espelid H
      – PersonEntity:
          Name:
            NameFull: Geisler J
      – PersonEntity:
          Name:
            NameFull: Geisler S
      – PersonEntity:
          Name:
            NameFull: Janssen EAM
      – PersonEntity:
          Name:
            NameFull: Yndestad S
      – PersonEntity:
          Name:
            NameFull: Minsaas L
      – PersonEntity:
          Name:
            NameFull: Leirvaag B
      – PersonEntity:
          Name:
            NameFull: Lillestøl R
      – PersonEntity:
          Name:
            NameFull: Knappskog S
      – PersonEntity:
          Name:
            NameFull: Lønning PE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 12
              Text: 2023 Dec 06
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1756-994X
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Genome medicine
              Type: main
ResultId 1